Pilot Study to Develop Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Carcinomatosis in Patients with Metastatic Solid Tumor Cancer
The purpose of this study is to learn whether the DNA from cancer tumor cells can be found
in the cerebral spinal fluid (CSF) that bathes the brain and spinal cord of patients before
malignant the cancer cells themselves are able to be found in the CSF. The researchers doing
this study hope this information can be used to develop a way to diagnose LM earlier .
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.